Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

@inproceedings{Arshad2016TowardsTC,
  title={Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer},
  author={Osama A. Arshad and Aniruddha Datta},
  booktitle={BMC Bioinformatics},
  year={2016}
}
Prostate cancer is one of the most prevalent cancers in males in the United States and amongst the leading causes of cancer related deaths. A particularly virulent form of this disease is castration-resistant prostate cancer (CRPC), where patients no longer respond to medical or surgical castration. CRPC is a complex, multifaceted and heterogeneous malady… CONTINUE READING